Subscribe

    NP+PA Perspectives in Dermatology: January-February 2025

    Categories:

    Click the cover to access the digital edition of NPPA January-February 2025

    Share:

    Recent Articles:

    Hadas Skupsky, MD, FAAD: Pigmented Lesion Management for the Dermatologist
    Read More
    Letters to the Editor: May 2025
    Read More
    Tralokinumab as a Therapeutic Alternative for Dupilumab-associated Arthralgia in Atopic Dermatitis: A Multi-center Case Series
    Read More
    The Correlation between Hidradenitis Suppurativa and Irritable Bowel Diseases: A Systematic Review
    Read More
    A Clinician’s Guide to Dupilumab-related Ocular Surface Disease
    Read More
    A Review of Neoadjuvant PD-1 Inhibitors in the Setting of Cutaneous Malignancies
    Read More
    The Treatment of Pembrolizumab-induced Pruritus with Topical Roflumilast Cream 0.3% Once Daily
    Read More
    Ferulic Acid Use for Skin Applications: A Systematic Review
    Read More
    Safety Evaluation of Topical Products Containing Live Cultures and Ferment of Cutibacterium Acnes Subspecies Defendens Strain XYCM42 in Individuals Predisposed to Acne Vulgaris
    Read More
    Interpreting Safety Analyses in Psoriasis Clinical Trials
    Read More
    1 2 3 … 164
    Facebook X-twitter Linkedin

    Categories:

    Recent Articles:

    James Del Rosso, DO, and Christopher Bunick, MD: Tralokinumab as a Therapeutic Alternative for Dupilumab-associated Arthralgia in Atopic Dermatitis—A Multi-center Case Series
    Read More
    Michael Cameron, MD, FAAD, and Christopher Bunick, MD, PhD: The Future of Personalized Atopic Dermatitis Treatments to Predict and Avoid Adverse Events
    Read More
    Naiem Issa, MD, PhD, and Christopher Bunick, MD, PhD: Mechanisms of Dupilumab-associated Arthralgia in Patients with Atopic Dermatitis
    Read More
    Hadas Skupsky, MD, FAAD: Pigmented Lesion Management for the Dermatologist
    Read More
    Jennifer Silva, APRN-DNP: Safety Considerations for Treating Patients with Vitiligo
    Read More
    Letters to the Editor: May 2025
    Read More
    Tralokinumab as a Therapeutic Alternative for Dupilumab-associated Arthralgia in Atopic Dermatitis: A Multi-center Case Series
    Read More
    The Correlation between Hidradenitis Suppurativa and Irritable Bowel Diseases: A Systematic Review
    Read More
    A Clinician’s Guide to Dupilumab-related Ocular Surface Disease
    Read More
    A Review of Neoadjuvant PD-1 Inhibitors in the Setting of Cutaneous Malignancies
    Read More
    1 2 3 … 202

    Tags:

    JCAD

    Journal of Clinical and Aesthetic Dermatology

    Facebook-f X-twitter Instagram Linkedin

    ©2025 JCAD | The Journal of Clinical and Aesthetic Dermatology. All Rights Reserved.